NCT06410742

Brief Summary

Following the guidance of individuals with primary Sjögren's Syndrome who receive diagnosis, routine medical care, and treatment management, the evaluations will be performed once by the researchers and will take approximately one hour. In addition, healthy individuals with a similar average age to the evaluation group without any disease diagnosis will be included in the study as a control group. Evaluations of the healthy group will be made once by the researchers and will take approximately one hour. Data will be collected face to face at the Faculty of Physical Therapy and Rehabilitation, Rheumatology Unit. Data collection tool of the research:

  • Information about patients will be recorded with the Demographic Information Form.
  • EULAR Sjögren's Syndrome Disease Activity Index
  • EULAR Sjögren's Syndrome Patient Reporting Index
  • Primary Sjögren's Syndrome Quality of Life Scale
  • BETY-Biopsychosocial Questionnaire
  • Central Sensitization Scale
  • Pain Catastrophizing Scale
  • Hospital Anxiety and Depression Scale
  • Multidimensional Fatigue Rating Scale
  • Turkish Eating Assessment Tool
  • Yale Swallow Protocol
  • Test of Mastication and Swallowing Solids
  • Dysphagia Limit Test
  • Xerostomia inventory

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 13, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 19, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

February 28, 2025

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

May 6, 2024

Last Update Submit

February 26, 2025

Conditions

Keywords

Sjogren' Syndromecorrelationxerostomiadryness

Outcome Measures

Primary Outcomes (7)

  • BETY-Biopsychosocial Questionnaire (BETY-BQ)

    BETY-BQ consists of the following six subtitles that investigate in detail the biopsychosocial dimensions: pain, functionality and fatigue, mood, sociability, sexuality, and sleep quality. This scale consists of 30 items, scored on a 5-point Likert system. Each question is scored as "No never: 0 Yes rarely: 1 Yes sometimes: 2 Yes often: 3 Yes always: 4" and a total score over 30 items. A higher score indicates a poorer biopsychosocial situation.

    baseline

  • Turkish Eating Assessment Tool

    Turkish Eating Assessment Tool is a survey consisting of 10 questions with a Likert scale between 0 and 4 (0 = no problem, 4 = severe problem). The total score is calculated out of 40 points by finding the sum of the answers given by individuals to each question. A score of 3 or more in the survey is considered abnormal. A score of 16 or above is considered as suspicion of aspiration.

    baseline

  • Xerostomia inventory

    The scale consists of 11 items. Patients will be asked to choose the best response for each item describing their symptoms over the previous two weeks. Responses are scored from 1 to 5 (1: never, 2: rarely, 3: occasionally, 4: fairly often, and 5: very often). The sum of the item scores gives a total score ranging from 11 to 55, and a higher score indicates that the symptoms are more severe.

    baseline

  • Multidimensional Fatigue Rating Scale

    This scale evaluates fatigue with 16 items under 5 subheadings: degree, severity, impact on daily activities, troubles it causes, and fatigue time. The score ranges from 0 (not tired) to 50 (extremely tired).

    baseline

  • Hospital Anxiety and Depression Scale (HADS)

    In this scale consisting of fourteen questions, odd-numbered questions questioning anxiety, and even questions question depression. Options range from 0 to 3, with a higher score indicating a poor emotional state. The cut-off values of the scale were determined as 10 for the anxiety subscale and 7 for the depression subscale.

    baseline

  • Test of Mastication and Swallowing Solids

    In our study, the Test of Masticating and Swallowing Solids (TOMASS) will be used. The test evaluates how many bites the individual takes to eat a biscuit while sitting upright, how many chewing cycles he makes, how many times he swallows it, and how long the total time is from biting to swallowing. Video recording will be taken during the test. The number of bites, number of chewing cycles, number of swallows and total time will be calculated on the video.

    baseline

  • Dysphagia limit

    While evaluating dysphagia, individuals are given 5, 10, 15, 20, 25, 30, 35, 40 and 45 mL volumes of liquid, respectively, with a graduated syringe and are asked to swallow the liquid. The maximum amount of fluid that the thyroid cartilage can swallow during a single movement is determined. The normal dysphagia limit in healthy individuals is more than 20 mL. If a person can swallow 20 mL normally, the dysphagia limit is normal.

    baseline

Secondary Outcomes (6)

  • Central Sensitization Scale

    baseline

  • Pain Catastrophizing Scale

    baseline

  • EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)

    baseline

  • EULAR Sjögren's Syndrome Patient Reporting Index (ESSPRI)

    baseline

  • Primary Sjögren's Syndrome Quality of Life Scale

    baseline

  • +1 more secondary outcomes

Study Arms (1)

Patients with primer Sjogren's syndrome

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals diagnosed with primary Sjögren's Syndrome according to the American European Consensus Criteria in Hacettepe University, Faculty of Medicine, Rheumatology Department, and volunteers to participate in the study will recruit this study. The total number of individuals to be included in the study will be calculated with 80% power and 95% confidence interval with the data obtained after the pilot study.

You may qualify if:

  • Patients diagnosed with Primary Sjögren's Syndrome
  • years or older

You may not qualify if:

  • Patients with Secondary Sjögren's Syndrome,
  • Patients who are diagnosed with other uncontrolled/clinically important diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system diseases, neurological, psychological diseases, etc.),
  • Having a malignant condition,
  • Pregnant individuals in the third trimester,
  • Individuals who do not agree to participate in the study and do not give written consent will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nazli Elif Nacar

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Sjogren's SyndromeXerostomia

Condition Hierarchy (Ancestors)

Arthritis, RheumatoidArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 13, 2024

Study Start

June 19, 2024

Primary Completion

December 30, 2024

Study Completion

January 1, 2025

Last Updated

February 28, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations